Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-12

Clinical Trial Update: A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Androderm's effect on blood pressure in adult males with hypogonadism has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androderm (testosterone)

Snippet

Sponsor: Allergan | Conditions: Hypogonadism | Phase 4 | Status: COMPLETED | Results posted: 2022-07-12